TY - JOUR
T1 - A novel filtration method for cord blood processing using a polyester fabric filter
AU - Shima, T.
AU - Forraz, N.
AU - Sato, N.
AU - Yamauchi, T.
AU - Iwasaki, H.
AU - Takenaka, Katsuto
AU - Akashi, K.
AU - Mcguckin, C.
AU - Teshima, T.
N1 - Copyright:
Copyright 2014 Elsevier B.V., All rights reserved.
PY - 2013/8
Y1 - 2013/8
N2 - Introduction: Cord blood (CB) is being increasingly used as a source of hematopoietic stem cells for transplantation to treat diseases of the blood and immune systems, and there is an urgent need to expand CB banking worldwide. CB processing requires costly machinery or a clean room that hampers wider application of CBT particularly in the developing countries. Methods: We developed a novel filtration system using a nonchemical-coated and nonwoven polyester fabric filter, which traps cells through affinity and does not require centrifugation or potentially toxic chemicals. Results: Cell processing with the device resulted in minimum cell loss of total cells and CD34+ cells, without impairing the ability of CD34+ cells to engraft and differentiate both in vivo and in vitro. Conclusion: CB processing with this device is simple, cost-effective, and nontoxic without requiring costly equipment will thus facilitate international CB banking, which helps in meeting the increasing worldwide demand for CB for allogeneic hematopoietic stem cell transplantation.
AB - Introduction: Cord blood (CB) is being increasingly used as a source of hematopoietic stem cells for transplantation to treat diseases of the blood and immune systems, and there is an urgent need to expand CB banking worldwide. CB processing requires costly machinery or a clean room that hampers wider application of CBT particularly in the developing countries. Methods: We developed a novel filtration system using a nonchemical-coated and nonwoven polyester fabric filter, which traps cells through affinity and does not require centrifugation or potentially toxic chemicals. Results: Cell processing with the device resulted in minimum cell loss of total cells and CD34+ cells, without impairing the ability of CD34+ cells to engraft and differentiate both in vivo and in vitro. Conclusion: CB processing with this device is simple, cost-effective, and nontoxic without requiring costly equipment will thus facilitate international CB banking, which helps in meeting the increasing worldwide demand for CB for allogeneic hematopoietic stem cell transplantation.
UR - http://www.scopus.com/inward/record.url?scp=84880638724&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84880638724&partnerID=8YFLogxK
U2 - 10.1111/ijlh.12039
DO - 10.1111/ijlh.12039
M3 - Article
C2 - 23241085
AN - SCOPUS:84880638724
SN - 1751-5521
VL - 35
SP - 436
EP - 446
JO - International Journal of Laboratory Hematology
JF - International Journal of Laboratory Hematology
IS - 4
ER -